Delivery Order SPE2DB20D3103-SPE2DB22FP9X4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,544.27 firm fixed-price delivery order is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 19, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VEMLIDY 25 MG TABLET UU 30S. The $17,342.53 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which runs through November 2026. This IDC enables efficient government procurement of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,357.98 firm fixed-price delivery order contract is for the supply of VEMLIDY 25 MG TABLET, a specific pharmaceutical product. The contract has an ultimate completion date of January 23, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,661.42 firm fixed-price delivery order is for the supply of VEMLIDY 25 MG TABLET, a pharmaceutical product, with a period of performance through November 29, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This federal contract award, valued at $12,531.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a medical product. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,346.02, is a Firm Fixed Price Delivery Order for the supply of VEMLIDY 25 MG TABLET UU 30S, a medical product. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,772.24 Firm Fixed Price Delivery Order contract provides the DLA with VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The award has a completion date of September 13, 2024. This contract is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $8,153.17 with a firm fixed price awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 25, 2024 and covers the procurement of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,750.04, is for the delivery of VEMLIDY 25 MG TABLET medical products. The contract is a Firm Fixed Price Delivery Order with a completion date of February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,301.43 firm fixed-price delivery order contract is for the supply of VEMLIDY 25 MG TABLET, a medication used in the treatment of certain medical conditions. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2024. This award is associated with a larger...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP9X4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $53,244.62 firm fixed-price delivery order is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of September 23, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.2k | 9/22/22 |